|
시장보고서
상품코드
1509673
세계의 의료용 방사선 검출 시장 평가 : 검출기 유형별, 제품 유형별, 최종사용자별, 지역별, 기회, 예측(2017-2031년)Medical Radiation Detection Assessment, By Detector Type, By Product Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
||||||
세계 의료용 방사선 검출 시장 규모는 2023년 11억 3,000만 달러에서 2031년 19억 5,000만 달러에 달할 것으로 예상되며, 예측 기간인 2024년부터 2031년까지 연평균 7.04% 성장할 것으로 예상됩니다. 이 시장은 최근 몇 년 동안 괄목할 만한 성장세를 보였으며, 앞으로도 강력한 성장세를 유지할 것으로 예상됩니다.
의료용 방사선 검출은 주변 사람들의 안전을 보장하는 도구와 장비를 사용하는 데 필요합니다. 위험한 방사선은 의료용 방사선 안전, 모니터링 및 감지에 사용되는 장비에 의해 식별되고 감소됩니다. 의료용 방사선 검출 및 모니터링은 영상 진단센터, 병원 등 작업장에서 안전한 방사선 환경을 제공하기 위해 고안된 것으로, 환경의 방사선 수준뿐만 아니라 작업자의 피폭량도 확인합니다.
전 세계 각국 정부는 의료용 방사선 사용을 관리하기 위한 법과 규정을 마련하여 방사선 노출의 위험성을 이해하고 관리하고 있습니다. 예를 들어, 미국 식품의약국(FDA)은 의료 영상으로 인한 방사선 피폭을 줄이기 위해 의료 종사자를 위한 가이드라인을 발표했으며, FDA는 불필요한 영상 검사를 하지 않고 진단적 품질의 영상을 얻기 위해 필요한 최소 방사선량을 사용할 것을 권장하고 있습니다. 또한, Centers for Medicare and Medicaid Services(CMS)도 첨단 영상 진단 서비스의 적절한 사용을 장려하기 위한 노력을 기울이고 있습니다. 의료용 영상의 필요성과 함께 의료용 방사선 검출기의 필요성도 확대되고 있습니다. 의료관광은 매우 인기 있고 현재 널리 받아들여지고 있습니다. 정부는 많은 투자와 인프라 개발의 형태로 이에 기여하고 있습니다. 연구 개발은 방사선량을 감지하고 사용자와 의료 기술자가 불필요한 방사선에 노출되지 않도록 하는 최고의 첨단 기술을 강력하게 지원하고 있습니다.
예를 들어, 2022년 Infab, LLC(미국)는 혁신적인 제품인 903 Reverse Vest & Skirt를 출시했습니다. 이 제품은 다양한 디자인과 모델을 갖추고 있으며, 높은 수준의 방사선 보호 기능을 제공합니다.
암 발병률의 증가로 시장 성장 촉진
방사선 치료는 암 치료에 필수적이며, 암은 전 세계 주요 사망 원인 중 하나입니다. 방사선 치료는 암 환자의 증가로 인해 수요가 증가하고 있습니다. 예를 들어, 미국암학회(American Cancer Society)가 2024년에 발표한 자료에 따르면, 미국에서는 2024년에 200만 1,140명의 암 환자가 새로 발생하고 61만 1,720명이 사망할 것으로 예측됩니다. 치료 중 환자가 적절한 양의 방사선을 받도록 보장하기 위해 정확하고 효율적인 방사선 검출 시스템의 필요성이 주목을 받고 있으며, CT, PET, X선 등 이온화 방사선을 사용하는 영상 진단 방법은 암 진단에 자주 사용됩니다. 암 환자 수가 증가함에 따라 영상 진단의 필요성이 증가함에 따라 치료 중인 환자를 보호하는 방사선 검출기에 대한 필요성이 증가하고 있습니다.
정밀의료와 맞춤 치료 요법은 암 치료의 발전 방향입니다. 방사선 치료는 점점 더 환자 맞춤형으로 집중화되어 가고 있습니다. 건강한 조직의 손상을 최소화하면서 종양에 조사되는 방사선량을 정확하게 평가하고 관리하기 위해서는 정밀한 방사선 검출기를 사용해야 합니다. 환자가 부작용을 최소화하면서 적절한 치료를 받을 수 있도록 의료 시설과 의료진은 방사선량을 모니터링하고 검증하기 위해 방사선 검출기에 투자하고 있습니다. 방사선 안전 규제는 규제 당국에 의해 더욱 엄격하게 시행되고 있습니다. 의료 시설은 신뢰할 수 있는 방사선 검출기 사용을 의무화하는 이러한 기준을 준수해야 합니다. 위반 시 처벌, 법적 처벌, 시설에 대한 사회적 비난이 발생할 수 있기 때문에 규정 준수 솔루션에 대한 요구가 증가하고 있습니다.
R&D 투자 증가로 시장 활성화
방사선 검출 기술 개발은 R&D 비용에 의해 뒷받침되고 있습니다. 여기에는 보다 민감한 검출기 개발, 데이터 처리를 위한 고급 알고리즘 개발, 다른 의료 시스템과의 시스템 통합 등이 포함됩니다. 환자의 안전과 진단 및 치료의 정확성을 높이고자 하는 의료 서비스 제공자들은 혁신적인 솔루션에 매료되어 시장 확대에 박차를 가하고 있습니다. 연구개발에 대한 투자로 성능 지표가 강화된 방사선 검출 도구가 개발되고 있습니다. 그 결과, 신뢰성이 향상되고, 검출 한계가 낮아지고, 선량 측정 정확도가 향상되고 있습니다.
이 보고서는 세계 의료용 방사선 검출 시장에 대해 조사 분석했으며, 시장 규모와 예측, 시장 역학, 주요 기업 현황 및 전망 등을 제공합니다.
Global medical radiation detection market is projected to witness a CAGR of 7.04% during the forecast period 2024-2031F, growing from USD 1.13 billion in 2023 to USD 1.95 billion in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.
Medical radiation detection is necessary for using tools and devices to ensure the safety of everyone around it. Hazardous radiation is identified and lessened by the devices used for medical radiation safety, monitoring, and detection. To provide safe radiological circumstances in places of employment, such as imaging centers and hospitals, medical radiation detection, and monitoring is devised to keep a check on radiation levels in the environment as well as its exposure to the working professional.
All around the world, governments have put laws and regulations in place to control the use of medical radiation as they understand the possible risks involved. To help reduce radiation exposure from medical imaging, the Food and Drug Administration (FDA) in the United States, for instance, has released guidelines to healthcare professionals. The FDA advises against doing needless imaging exams and to use the lowest radiation dose required to produce a diagnostic-quality image. Another initiative to promote the appropriate use of advanced diagnostic imaging services has been put in place by the Centres for Medicare and Medicaid Services (CMS). The necessity for medical radiation detection equipment has expanded along with the need for medical imaging. Medical Tourism is becoming very popular and is now widely accepted. The government has contributed to it in the form of heavy investments and infrastructure. Research and development have strongly supported the best and most advanced technology, which detects the radiation doses and prevents from getting more than the required radiation to its users and the healthcare technicians.
For instance, in 2022, Infab, LLC (USA) introduced its innovative product, the 903 Reverse Vest & Skirt, designed to offer robust protection against scatter radiation while ensuring a secure and comfortable fit for users. It has a wide range of products in different designs and models and offers a high-level protection against radiation.
Rising Incidence of Cancer to Boost the Market
Radiation therapy is an essential part of cancer treatment and cancer is one of the main causes of deaths globally. Radiation therapy is getting more in demand due to the number of cancer patients. For instance, according to data published by a journal of American Cancer Society in 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. To guarantee that patients receive the appropriate dosage of radiation during treatment, the necessity for precise and efficient radiation detection systems comes into light. Imaging methods that use ionizing radiation, such as CT, PET, and X-rays, are frequently used in the diagnosis of cancer. As the number of cancer cases rises, the need for diagnostic imaging increases the need for radiation detection equipment to protect patients during these treatments.
Precision medicine and individualized treatment regimens are the direction of advancements in cancer care. Radiation therapy is getting increasingly patient-specific and focused. To precisely assess and manage the radiation dose delivered to tumors while minimizing damage to healthy tissues, precision necessitates the use of sophisticated radiation detection devices. To ensure that patients receive the appropriate therapy with the fewest possible side effects, healthcare facilities and practitioners are investing in radiation detection equipment to monitor and verify radiation doses. Radiation safety regulations are being enforced by regulatory bodies in a more rigorous manner. These standards, which require the use of trustworthy radiation detection equipment, must be followed by healthcare establishments. Penalties, legal repercussions, and reputational harm to a facility are possible outcomes of non-compliance, which increases demand for compliant solutions.
Increasing R&D Investments to Fuel the Market
The development of radiation detection technologies is fueled by research and development expenditures. It includes the creation of detectors that are more sensitive, sophisticated algorithms for data processing, and system integration with other healthcare systems. Healthcare providers seeking to enhance patient safety and diagnostic or therapeutic precision are drawn towards innovative solutions, hence propelling the market expansion. Investments in R&D result in the development of radiation detection tools with enhanced performance metrics. It entails improved dependability, decreased detection limits, and enhanced dose measurement accuracy.
The market demand is increasing as healthcare facilities look for these devices to maximize radiation therapy and diagnostic processes. The systems' flexibility to accommodate diverse medical domains such as cardiology, radiology, or oncology eventually increases their attractiveness to healthcare providers. The advancement of real-time monitoring capabilities is facilitated by ongoing R&D investments. It improves patient safety by enabling healthcare providers to monitor radiation exposure in real-time during procedures and make quick modifications as needed. Such real-time monitoring systems are in high demand, which drives market expansion. It is becoming more crucial to integrate radiation detection data with electronic health records. By facilitating data-driven decision-making and quality enhancement, integration promotes market growth. Investments in R&D produce advances which allow radiation doses to be lowered while preserving therapeutic and diagnostic efficacy. It is especially important for radiation therapy and medical imaging since it follows the ALARA (As Low as Reasonably Achievable) philosophy.
Radiation detection systems' primary selling point, which propels their adoption, is reduced radiation exposure. Integration of AI and radiology is a blessing to the healthcare industry. Heavy research and development across the globe are going on to produce the best results. It presents a great opportunity for the market to expand. For instance, recently in February 2024, Kormek Group was awarded EUR 1.3 million to participate in the Intelligent Radiation Sensor Readout System (i-RASE) project for developing a new class of radiation sensor powered by artificial intelligence (AI).
Dominance of Personal Dosimeters Segment
The sector of personal dosimeters holds a notable market share owing to its vital function in ensuring the safety of radiation professionals and healthcare personnel. People who are exposed to ionizing radiation use personal dosimeters, which allow them to monitor their radiation exposure levels in real time. The need for personal dosimeters has increased due to rising radiation safety awareness, strict regulatory requirements, and an increase in the number of radiation-related diagnostic and therapeutic procedures. The industry's dedication to maintaining worker safety and adhering to radiation protection regulations is seen in the segment's significance, which in turn contributes to its sizeable market share. When workers are in locations where radiation exposure poses a risk, personal dosimeters are used to track their radiation exposure levels. It is especially crucial for ionizing radiation-exposed businesses such as radiography, nuclear power, and medical imaging. By preventing workers from being exposed to hazardous radiation levels, it safeguards their health and well-being. Advanced personal dosimeters are being introduced lately by healthcare players as well. For instance, in 2023, Tracerco, which is one of the most leading brands for providing radiation monitoring equipment, announced the range of its next generation personal electronic dosimeters that will provide clients with a patented detection technology to enhance radiological safety performance.
North America to Dominate Medical Radiation Detection Market
Market share in terms of value is the highest in North America, which has emerged as the leading region in the medical radiation detection industry. High prevalence of cancer has led to high demand of diagnosis and monitoring which drives the need for advanced imaging technologies such as X-ray, CT, and MRI, which are facilitated by radiology. As per December 2022 CDC data, a significant portion of the United States population (60%) suffers from chronic illnesses, with 40% having multiple chronic conditions.
North America boasts a well-developed healthcare system, providing the necessary infrastructure and support for the adoption and integration of advanced radiology services which again makes it prone to become the largest market. Plus, increased government funding in healthcare, evidenced by the National Institutes of Health data showing a rise in the United States healthcare expenditure for biomedical imaging from USD 2.774 billion in 2022 to USD 3.101 billion in 2023, fuels advancements in radiation detection market. Leading players in the region, such as United Imaging Healthcare's launch of their 5.0T MRI scanner in March 2023, contribute to market growth by introducing innovative radiology tools that again promote the global medical radiation detection market.
Future Market Scenario (2024 - 2031F)
As time advances, so is technology. One of the biggest boons of technology in healthcare is integration of AI with radiology. The rising need to diagnose diseases using imaging procedures is met due to the availability of radiology. However, radiation when used in more amounts than required can be dangerous. It introduces the need for radiation detection devices which regulate and control the amount of radiation given to the patient. Also, it prevents the healthcare professionals from being exposed to it. Undoubtedly, radiology is the topmost segment in healthcare in terms of market size and shares. Growth of medical radiation detection market goes parallel to growth of radiology sector. It presents us with a high potential market to invest in. The government along with large pharmaceutical giants are coming together and introducing the most cutting-edge technology to the market. Medical tourism is one sector that is widely accepted in almost every nation, worldwide. The market's expansion is crucial for the betterment of the healthcare industry on a holistic level. For instance, the National Health Expenditure Projections 2023-2024 predict that, due to the assumption that patient care patterns will return to pre-pandemic levels, growth rates in the United States health expenditures will be 5% this year and 5.1% in the next year.
Key Players Landscape and Outlook
There are a number of significant competitors in the competitive market of medical radiation detection. Presently, a number of the key competitors control the majority of the market share. These companies are leading the market share due to their continuous efforts toward R&D, technological advancements and drug development that is effective and reliable.
In November 2023, TeleDaaS PLC, a leading service provider of radiation detection, made its debut in the Radiological Society of North America. They have launched TeleDaaS to aid research and development in cancer. The goal of TeleDaaS is to revolutionize cancer therapy research and development by offering highly scalable, best-in-class dosimetry services that interface with current imaging workflows.
In November 2023, Mayo Clinic and GE Healthcare established a strategic partnership for research and product development initiatives aimed to improve patient and physician experiences with radiology and the delivery of innovative treatments.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.